Dried Blood Spot Testing Some functional medicine practitioners use dried blood spot kits that can be used at home
Summary of the GLP-1 Receptor Agonist Market Demand and Growth Drivers Rising obesity and diabetes prevalence is expected to increase physician interest in therapies with metabolic and cardiovascular benefits
Adv Pediatr 33:95126 Gretz N, Manz F, Augustin R, Barrat TM, Bender-Gotze C, Brandis M, Bremer HJ, Brodehl J, Broyer M, Bulla M, Callis L, Chantler C, Diekmann L, Dillon MJ, Egli F, Ehrich JH, Endres W, Fanconi A, Feldhoff C, Geisert J, Gekle D, Gescholl-Bauer B, Grote K, Gruttner R, Hagge W, Haycock CB, Hennemann H, Klare B, Leupold D, Lohr H, Michalk D, Oliveira A, Ott F, Pistor K, Rau J, Scharer K, Schindera F, Schmidt H, Schulte-Wissermann H, Verrier-Jones K, Weber HP, Willenbockel U, Wolf H (1983) Survival time in cystinosis
First, SURMOUNT-1 (obesity) enrolled a different, generally healthier population than SURPASS (diabetes), which is why its weight-loss numbers are larger the same drug loses less weight in people with diabetes